Table 8. Congenital Syphilis — Distribution of Receipt of Testing and Treatment by Pregnant Persons with a Congenital Syphilis Outcome by State/Territory and Region in Alphabetical Order, United States

About

The table below is from Sexually Transmitted Infections Surveillance, 2023.

2023

State/Territory Total # of CS cases Testing Treatment Outcome
No or nontimely testing Late identification of seroconversion Inadequate treatment No or nondocumented treatment Clinical evidence of CS despite adequate prenatal treatment Insufficient data to identify the missed opportunity
N % N % N % N % N % N %
Alabama 41 15 36.6 17 41.5 1 2.4 2 4.9 6 14.6 0 0.0
Alaska 10 ND — ND — ND — ND — ND — ND —
Arizona 233 77 33.0 39 16.7 57 24.5 43 18.5 6 2.6 11 4.7
Arkansas 64 19 29.7 13 20.3 14 21.9 11 17.2 5 7.8 2 3.1
California 512 294 57.4 21 4.1 100 19.5 75 14.6 6 1.2 16 3.1
Colorado 51 27 52.9 2 3.9 6 11.8 9 17.6 3 5.9 4 7.8
Connecticut 2 ND — ND — ND — ND — ND — ND —
Delaware 5 ND — ND — ND — ND — ND — ND —
District of Columbia 5 ND — ND — ND — ND — ND — ND —
Florida 235 109 46.4 10 4.3 49 20.9 30 12.8 16 6.8 21 8.9
Georgia 127 42 33.1 17 13.4 23 18.1 35 27.6 3 2.4 7 5.5
Hawaii 21 12 57.1 1 4.8 7 33.3 0 0.0 1 4.8 0 0.0
Idaho 0 0 — 0 — 0 — 0 — 0 — 0 —
Illinois 100 32 32.0 8 8.0 22 22.0 14 14.0 7 7.0 17 17.0
Indiana 50 16 32.0 1 2.0 17 34.0 2 4.0 8 16.0 6 12.0
Iowa 12 7 58.3 2 16.7 2 16.7 1 8.3 0 0.0 0 0.0
Kansas 15 7 46.7 2 13.3 4 26.7 0 0.0 0 0.0 2 13.3
Kentucky 47 17 36.2 2 4.3 8 17.0 8 17.0 9 19.1 3 6.4
Louisiana 109 28 25.7 15 13.8 27 24.8 31 28.4 4 3.7 4 3.7
Maine 2 ND — ND — ND — ND — ND — ND —
Maryland 69 28 40.6 7 10.1 22 31.9 7 10.1 5 7.2 0 0.0
Massachusetts 14 7 50.0 0 0.0 5 35.7 1 7.1 0 0.0 1 7.1
Michigan 55 24 43.6 7 12.7 11 20.0 5 9.1 2 3.6 6 10.9
Minnesota 29 11 37.9 1 3.4 8 27.6 8 27.6 0 0.0 1 3.4
Mississippi 131 43 32.8 11 8.4 33 25.2 26 19.8 5 3.8 13 9.9
Missouri 94 29 30.9 8 8.5 31 33.0 14 14.9 4 4.3 8 8.5
Montana 19 8 42.1 0 0.0 5 26.3 2 10.5 0 0.0 4 21.1
Nebraska 14 5 35.7 0 0.0 4 28.6 1 7.1 3 21.4 1 7.1
Nevada 77 49 63.6 0 0.0 16 20.8 6 7.8 2 2.6 4 5.2
New Hampshire 1 ND — ND — ND — ND — ND — ND —
New Jersey 43 19 44.2 11 25.6 3 7.0 4 9.3 3 7.0 3 7.0
New Mexico 91 45 49.5 2 2.2 29 31.9 7 7.7 4 4.4 4 4.4
New York 67 28 41.8 6 9.0 10 14.9 7 10.4 4 6.0 12 17.9
North Carolina 72 36 50.0 13 18.1 5 6.9 9 12.5 1 1.4 8 11.1
North Dakota 2 ND — ND — ND — ND — ND — ND —
Ohio 74 27 36.5 14 18.9 15 20.3 11 14.9 5 6.8 2 2.7
Oklahoma 79 38 48.1 10 12.7 12 15.2 10 12.7 9 11.4 0 0.0
Oregon 30 25 83.3 0 0.0 2 6.7 0 0.0 0 0.0 3 10.0
Pennsylvania 37 19 51.4 2 5.4 8 21.6 3 8.1 1 2.7 4 10.8
Rhode Island 2 ND — ND — ND — ND — ND — ND —
South Carolina 30 15 50.0 1 3.3 2 6.7 6 20.0 5 16.7 1 3.3
South Dakota 54 19 35.2 5 9.3 21 38.9 5 9.3 3 5.6 1 1.9
Tennessee 88 40 45.5 6 6.8 18 20.5 12 13.6 8 9.1 4 4.5
Texas 930 334 35.9 58 6.2 54 5.8 450 48.4 20 2.2 14 1.5
Utah 16 10 62.5 0 0.0 4 25.0 1 6.2 0 0.0 1 6.2
Vermont 0 0 — 0 — 0 — 0 — 0 — 0 —
Virginia 21 11 52.4 3 14.3 3 14.3 2 9.5 2 9.5 0 0.0
Washington 57 36 63.2 3 5.3 10 17.5 7 12.3 1 1.8 0 0.0
West Virginia 18 9 50.0 1 5.6 7 38.9 0 0.0 0 0.0 1 5.6
Wisconsin 25 14 56.0 0 0.0 3 12.0 4 16.0 0 0.0 4 16.0
Wyoming 2 ND — ND — ND — ND — ND — ND —
US TOTAL 3882 1,648 42.5 320 8.2 685 17.6 872 22.5 163 4.2 194 5.0
Northeast 168 77 45.8 19 11.3 27 16.1 16 9.5 9 5.4 20 11.9
Midwest 524 193 36.8 48 9.2 138 26.3 65 12.4 32 6.1 48 9.2
South 2071 790 38.1 184 8.9 280 13.5 639 30.9 99 4.8 79 3.8
West 1119 588 52.5 69 6.2 240 21.4 152 13.6 23 2.1 47 4.2
American Samoa 0 0 — 0 — 0 — 0 — 0 — 0 —
Commonwealth of the Northern Mariana Islands 0 0 — 0 — 0 — 0 — 0 — 0 —
Guam 1 ND — ND — ND — ND — ND — ND —
Puerto Rico 27 7 25.9 14 51.9 3 11.1 3 11.1 0 0.0 0 0.0
US Virgin Islands 0 0 — 0 — 0 — 0 — 0 — 0 —
TERRITORIES TOTAL 28 8 28.6 14 50.0 3 10.7 3 10.7 0 0.0 0 0.0
TOTAL 3910 1,656 42.4 334 8.5 688 17.6 875 22.4 163 4.2 194 5.0
ND = Not displayed. Missed opportunities categories for jurisdictions who had ≤10 cases total are not displayed.

NOTE: See Technical Notes for more information on syphilis case reporting and methodology for missed prevention opportunity categorization. This report includes data from years that coincide with the COVID-19 pandemic, which introduced uncertainty and difficulty in interpreting case data. See Impact of COVID-19 on STIs for more information. Tennessee transitioned STI surveillance information systems in September of 2023 which may have impacted the overall case counts. Caution should be applied in interpretation of these data.
Print
Content Source:
National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention; About Division of STD Prevention